On December 31, 2013, Greg Berk, M.D. informed BIND Therapeutics, Inc. (the
"Company") of his intention to resign as the Company's Chief Medical Officer in
order to pursue another opportunity. Dr. Berk's resignation will be effective on
January 14, 2014. Dr. Berk is not resigning due to any disagreement with the
Company regarding its operations, policies or practices. The Company is
initiating a search for a new chief medical officer.